Home/Brixton Biosciences/Michael Fishman, MD

MF

Michael Fishman, MD

Chief Medical Officer

Brixton Biosciences

Therapeutic Areas

Pain Management Orthopedic Pain

Brixton Biosciences Pipeline

Drug	Indication	Phase
ReneuRx™ Therapy	Knee Pain (Orthopedic Pain)	Phase 1

Leadership Team at Brixton Biosciences

Chief Executive Officer

R. Rox Anderson, MD

Lilit Garibyan, MD

Chief Technology Officer

View full Brixton Biosciences profile